IDM CPD-ACCREDITED SEMINAR: A century of TB vaccine development

Professor Mark Hatherill is Director of the South African Tuberculosis Vaccine Initiative (SATVI), a University of Cape Town research group focused on understanding risk for and protection against TB, to develop better vaccines and therapies to impact the global epidemic.

His work focuses on the design and implementation of clinical trials of novel TB vaccines in children and adults.